Results 211 to 220 of about 3,681,465 (347)

Oral administration of Ketamir-2, a novel ketamine analog, attenuates neuropathic pain in rodent models via selective NMDA antagonism. [PDF]

Front Pharmacol
Angel I, Perelroizen R, Pichinuk E, Aminov E.   +3 more
europepmc   +1 more source

"Inclusion cell conjunctivitis" in calves

, 1951
H. POOK
openalex   +1 more source

Anisotropic Non-silicious Crystalline Inclusions in a Dysgerminoma of Tuberculoid Appearance [PDF]

, 1952
R. Eric Potts
openalex   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Workplace narratives of South African employees with multiple sclerosis. [PDF]

Afr J Disabil
Bam A, Bekker M, Ronnie L.
europepmc   +1 more source

Pharmaceutical Applications of Inclusion Compounds. III

, 1959
Hiroyuki Mima
openalex   +2 more sources

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Toward a more just and inclusive environmental psychology: moving beyond genderwashing and performative inclusion. [PDF]

Front Psychol
Pinho M.
europepmc   +1 more source

3: Relation of inclusion

, 1914
Louis Couturat
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source